Voya Investment Management LLC Rhythm Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 102,832 shares of RYTM stock, worth $5.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

102,832

Previous 37,811 171.96%

Holding current value

$5.77 Million

Previous $1.55 Million 247.1%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.81 - $55.0 $2.65 Million - $3.58 Million	65,021 Added 171.96%	102,832 $5.39 Million
Q2 2024 Dec 03, 2024	SELL	$35.41 - $44.37 $2.3 Million - $2.88 Million	-65,021 Reduced 63.23%	37,811 $1.55 Million
Q2 2024 Aug 14, 2024	SELL	$35.41 - $44.37 $4.67 Million - $5.85 Million	-131,900 Reduced 77.72%	37,811 $1.55 Million
Q1 2024 Dec 06, 2024	BUY	$39.12 - $52.44 $2.62 Million - $3.51 Million	66,879 Added 65.04%	169,711 $7.35 Million
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $4.1 Million - $5.49 Million	104,720 Added 161.13%	169,711 $7.35 Million
Q4 2023 Feb 14, 2024	SELL	$21.39 - $49.64 $412,142 - $956,463	-19,268 Reduced 22.87%	64,991 $2.99 Million
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $3,494 - $6,143	221 Added 0.26%	84,259 $1.93 Million
Q2 2023 Aug 14, 2023	BUY	$16.32 - $21.15 $333,629 - $432,369	20,443 Added 32.15%	84,038 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $273,458 - $1.96 Million	63,595 New	63,595 $1.56 Million
Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $53,713 - $210,896	-17,216 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.62 - $13.9 $370 - $597	-43 Reduced 0.25%	17,216 $172,000
Q2 2021 Aug 16, 2021	BUY	$18.52 - $22.55 $22,742 - $27,691	1,228 Added 7.66%	17,259 $338,000
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $25,616 - $49,954	1,265 Added 8.57%	16,031 $341,000
Q4 2020 Feb 16, 2021	BUY	$21.17 - $32.61 $55,888 - $86,090	2,640 Added 21.77%	14,766 $439,000
Q2 2020 Aug 14, 2020	SELL	$14.41 - $25.35 $38,474 - $67,684	-2,670 Reduced 18.05%	12,126 $270,000
Q1 2020 May 15, 2020	BUY	$13.16 - $22.9 $11,133 - $19,373	846 Added 6.06%	14,796 $225,000
Q4 2019 Feb 14, 2020	BUY	$19.53 - $25.5 $272,443 - $355,725	13,950 New	13,950 $320,000

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Rhythm Pharmaceuticals, Inc. Transaction History